Linda Rolnitzsky

Research Areas

Immune Response and Inflammation, Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches

Most-Cited Works

• → Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma(2015)91 cited